Impact Factor Collection

 

EJE impact factor graphic

The European Journal of Endocrinology's 2019 Impact Factor has risen to its highest ever ranking of 5.308, with the five-year measure also increasing to 5.077.

To celebrate the European Journal of Endocrinology's new Impact Factor, the journal Editorial Team have compiled a collection of highly cited articles contributing to the latest Impact Factor.

 

Highly cited in 2019

 

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
Gerald Raverot et al.

European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.

Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery
Yan Guo et al.

Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.

The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma
Emma S Scott et al.

GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing
Luigi Maione et al.

MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis
Ernesto Canalis et al.

Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH)
Marco Bonomi et al.

Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis
F Bolfi et al.

THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D Anastasilakis, Stergios A Polyzos and Polyzois Makras

DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
Richard Eastell et al.

Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules
A Lauria Pantano et al.

Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study
Daniela Esposito et al.

Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study
M Klaver et al.

MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
Tracy Ann Williams and Martin Reincke

DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-hydroxycortisol: is there clinical utility of these steroids?
Jacques W M Lenders et al.

GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’
L Audí et al.

Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures
Daniele Cassatella et al.

MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
Leandro Kasuki, Luiz Eduardo Wildemberg and Mônica R Gadelha

Identifying and treating subclinical thyroid dysfunction in pregnancy: emerging controversies
Inés Velasco and Peter Taylor